The French-Belgian medtech uses a portable headset to capture up to 800 infrared images per eye per second, extracting oculomotor biomarkers that can indicate Parkinson’s, Alzheimer’s, and multiple sclerosis years before clinical symptoms appear. It received CE certification in January 2025 and is targeting FDA clearance in 2026. neuroClues, a French-Belgian medtech company developing an […]<br /> This story continues at The Next Web [...]
The tenth generation of the Apple Watch came and went without much fanfare last year, and the arrival of the Series 11 is similarly subdued. Not much appears to have changed with Apple’s smartwatch, [...]
Apple’s September event put the spotlight on iPhones, but the Apple Watch Series 11 quietly picked up some big quality-of-life changes. The new watch looks the same as the Series 10, but there are m [...]
Microsoft has introduced a new AI system that could dramatically improve how complex medical cases are diagnosed, offering four times the diagnostic accuracy of experienced physicians while reducing c [...]
This Thursday is Global Accessibility Awareness Day (GAAD), and as has been its custom for the last few years, Apple's accessibility team is taking this time to share some new assistive features [...]
Everyone uses smartwatches differently. There are the people who wear them all day, those who only wear them when they’re outside, those who only use them while working out and even those who only w [...]